Skip to Main Content

Paper Details

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
J Thorac Oncol
3
2023
1q, 9p, Chromosome 9p, FAA, NSCLC, NSCLCs, Nonsquamous NSCLCs, PD-L1, Patients, RNA sequencing, Tumor, aneuploidy, cancer, chromosomal arm, chromosome 1q, chromosome 9p, chromosome arms, chromosomes, nonsquamous, nonsquamous NSCLCs, programmed cell death protein 1, programmed death-ligand 1, tumor, tumor-associated cytotoxic immune cells, tumors
Author NameAffiliation
Hira RizviMemorial Sloan Kettering Cancer Center
Andrew D CherniackDana-Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard
Andrew D CherniackDana-Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard
Marc LadanyiMemorial Sloan Kettering Cancer Center
Xihong LinHarvard T.H. Chan School of Public Health, Harvard University
Xihong LinHarvard T.H. Chan School of Public Health, Harvard University
Matthew MeyersonDana-Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard
Matthew MeyersonDana-Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard
  • 1 - 8

Datasets

Release 1.2